The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
CD19-targeted CAR T cells in refractory antisynthetase syndrome
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxicities of chimeric antigen receptor T cells: recognition and management
Brudno, J. N., & Kochenderfer, J. N. (2016) · Blood · doi:10.1182/blood-2016-04-703751 · Cited by 1,283
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Mackensen, A., Müller, F., Mougiakakos, D., Böltz, S., Wilhelm, A., Aigner, M., Völkl, S., Simon, D., Kleyer, A., Munoz, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02017-5 · Cited by 1,092
Self-citationIdiopathic inflammatory myopathies
Lundberg, I. E., Fujimoto, M., Vencovsky, J., Aggarwal, R., Holmqvist, M., Christopher-Stine, L., Mammen, A. L., & Miller, F. W. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00321-x · Cited by 703
Oddis, C. V., Reed, A. M., Aggarwal, R., Rider, L. G., Ascherman, D. P., Levesque, M. C., Barohn, R. J., Feldman, B. M., Harris‐Love, M. O., Koontz, D. C., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37754 · Cited by 701
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
Mougiakakos, D., Krönke, G., Völkl, S., Kretschmann, S., Aigner, M., Kharboutli, S., Böltz, S., Manger, B., Mackensen, A., & Schett, G. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2107725 · Cited by 610
Self-citationCavagna, L., Trallero-Araguás, E., Meloni, F., Cavazzana, I., Rojas-Serrano, J., Feist, E., Zanframundo, G., Morandi, V., Meyer, A., Pereira da Silva, J., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8112013 · Cited by 220
Self-citationAminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond
Galindo‐Feria, A. S., Notarnicola, A., Lundberg, I. E., & Horuluoglu, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.866087 · Cited by 97
Preuße, C., Paesler, B., Nelke, C., Cengiz, D., Müntefering, T., Roos, A., Amelin, D., Allenbach, Y., Uruha, A., Dittmayer, C., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02438-z · Cited by 64
Cited by
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
Müller, F., Taubmann, J., Bucci, L., Wilhelm, A., Bergmann, C., Völkl, S., Aigner, M., Rothe, T., Minopoulou, I., Tur, C., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2308917 · Cited by 1,095
Self-citationSun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
CAR T therapy beyond cancer: the evolution of a living drug
Baker, D. J., Arany, Z., Baur, J. A., Epstein, J. A., & June, C. H. (2023) · Nature · doi:10.1038/s41586-023-06243-w · Cited by 504
From bench to bedside: the history and progress of CAR T cell therapy
Mitra, A., Barua, A., Huang, L., Ganguly, S., Feng, Q., & He, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1188049 · Cited by 466
CAR T-cell therapy in autoimmune diseases
Schett, G., Mackensen, A., & Mougiakakos, D. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01126-1 · Cited by 430
Self-citation
Metadata
- Authors
- Müller, F., Boeltz, S., Knitza, J., Aigner, M., Völkl, S., Kharboutli, S., Reimann, H., Taubmann, J., Kretschmann, S., Rösler, W., Manger, B., Wacker, J., Mougiakakos, D., Jabari, S., Schröder, R., Uder, M., Roemer, F., Krönke, G., Mackensen, A., & Schett, G.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2023-03
- Volume
- 401
- Issue
- 10379
- Pages
- 815-818
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4320897339
- Cited by
- 260
- References
- 8
- FWCI
- 42.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CD19-targeted CAR T cells in refractory antisynthetase syndrome. https://app.cochat.ai/papers/10.1016/s0140-6736(23)00023-5
- The paper
- Müller, F., Boeltz, S., Knitza, J., Aigner, M., Völkl, S., Kharboutli, S., Reimann, H., Taubmann, J., Kretschmann, S., Rösler, W., Manger, B., Wacker, J., Mougiakakos, D., Jabari, S., Schröder, R., Uder, M., Roemer, F., Krönke, G., Mackensen, A., & Schett, G. (2023). CD19-targeted CAR T cells in refractory antisynthetase syndrome. The Lancet. https://doi.org/10.1016/s0140-6736(23)00023-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.